Omega Therapeutics (OMGAQ) Stock Chart & Stock Price History $0.0030 0.00 (0.00%) As of 08/11/2025 Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartHeadlinesInsider TradesOwnershipSEC FilingsShort InterestBuy This Stock Omega Therapeutics Stock Price Performance The Omega Therapeutics (OMGAQ) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.80%, with a year-to-date return of -99.60%. In the past month, the stock has decreased 92.94%, reflecting recent market activity. As of the latest close, Omega Therapeutics traded at $0.00 with a market cap of $166 thousand and volume of 0 shares. Receive OMGAQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day PerformanceN/A1 Month Performance-92.94%3 Month Performance-97.60%Year-To-Date Performance-99.60%1 Year Performance-99.80% OMGAQ Stock Chart for Friday, August, 22, 2025 OMGAQ Chart by TradingView Omega Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$0.00$0.00$0.01$0.0023,866 shs$166,000.0008/08/2025$0.00$0.00+50.00%$0.01$0.0023,866 shs$166,000.0008/07/2025$0.00$0.00+150.00%$0.01$0.0097,423 shs$111,000.0008/06/2025$0.02$0.00-95.90%$0.02$0.00146,100 shs$44,000.0008/05/2025$0.03$0.02-22.00%$0.03$0.02155,802 shs$1.08 million08/04/2025$0.02$0.03+38.89%$0.03$0.0221,011 shs$1.38 million08/01/2025$0.02$0.02-12.20%$0.02$0.02541 shs$997,000.0007/31/2025$0.02$0.02-1.44%$0.02$0.0235,599 shs$1.14 million07/30/2025$0.02$0.02+6.67%$0.02$0.0233,745 shs$1.15 million07/29/2025$0.02$0.02$0.02$0.025,357 shs$1.08 million Get the Latest News and Ratings for OMGAQ and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/28/2025$0.02$0.02+2.63%$0.04$0.0279,450 shs$1.08 million07/25/2025$0.02$0.02+2.70%$0.04$0.0263,309 shs$1.05 million07/24/2025$0.04$0.02-53.75%$0.03$0.0232,967 shs$1.02 million07/23/2025$0.04$0.04-5.88%$0.04$0.014,748 shs$2.22 million07/22/2025$0.04$0.04+6.25%$0.04$0.02118,953 shs$2.35 million07/21/2025$0.02$0.04+80.18%$0.05$0.01160,901 shs$2.22 million Related Companies BriaCell Therapeutics Stock Chart GLG Life Tech Stock Chart Nexien Biopharma Stock Chart Viracta Therapeutics Stock Chart Trevena Stock Chart Kaya Stock Chart MyMD Pharmaceuticals Stock Chart Bon Natural Life Stock Chart Vincerx Pharma Stock Chart Capstone Therapeutics Stock Chart Receive OMGAQ Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Omega Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OMGAQ) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omega Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omega Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access